Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus cream in plaque psoriasis
NCT00293917Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of Tacrolimus Ointment 0.1% Iwaki in plaque psoriasis, sponsored by Astellas Pharma. Primary endpoint: Safety at 12 months. Started Jan 2006; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00293917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293917.